课题基金 / 基金详情

CASE CONTROL STUDY OF HEMIFACIAL MICROSOMIA AND DRUG USE

CASE CONTROL STUDY OF HEMIFACIAL MICROSOMIA AND DRUG USE
半面畸形与药物使用的病例对照研究
批准号:
2897111
负责人:
MARTHA M. WERLER
金额:
$42.49万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2001-06-30

项目摘要

项目成果

MARTHA M. WERLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Investigator's Abstract) Hemifacial microsomia (HFM), the second most common craniofacial malformation, has significant functional and cosmetic consequences. While experimental evidence suggests a vascular etiology, there have been no published epidemiologic studies of risk factors for HFM, and its causes remain largely unknown. The proposed project is a multicenter case-control study of HFM in relation to 1) maternal exposure to decongestants, 2) maternal exposure to other vasoactive agents (such as alcohol, coffee, cigarette smoking, aspirin, and ibuprofen), 3) maternal exposure to other environmental risk factors (such as other medications, illness and nutritional factors); and 4) eventual studies of possible gene/environment interactions. There will be 250 case infants with HFM and 750 control infants without congenital malformations or medical conditions requiring hospitalization. Cases will be identified within 12 months of age at tertiary care institutions in 15 metropolitan areas in the U.S. and Canada. Controls will be identified by the case infant's primary physician and will comprise the next three infants born after the case. Mothers of cases and controls will be interviewed within three months after the date of case ascertainment by telephone. The standardized questionnaire inquires in detail about demographic factors; reproductive, medical and pregnancy illness histories; medication use; behaviors; and nutrition. Before the interview, each mother will be sent a medication identification booklet which includes color pictures of OTC products to help with recall. A separate component of the study will be collection of buccal cell samples from the study infant and his/her mother and father. Standardized photographs will be taken and the medical record of each case infant will be reviewed for HFM classification. Exposure prevalences will be compared between mothers of cases and controls and relative risks will be estimated, while controlling for potential confounding factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Massachusetts Center for Birth Defects Research and Prevention: Birth Defects Study To Evaluate Pregnancy exposureS (BD STEPS Core and Stillbirth)
Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation
  • 批准号:
    9883035
  • 项目类别:
  • 资助金额:
    $8.25万
  • 财政年份:
    2019
  • 负责人:
    MARTHA M. WERLER
  • 依托单位:
EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA
  • 批准号:
    9022193
  • 项目类别:
  • 资助金额:
    $31.0万
  • 财政年份:
    2015
  • 负责人:
    MARTHA M. WERLER
  • 依托单位:
EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA
  • 批准号:
    9290951
  • 项目类别:
  • 资助金额:
    $31.0万
  • 财政年份:
    2015
  • 负责人:
    MARTHA M. WERLER
  • 依托单位:
国内基金
海外基金
Aspirin调控AKT/Foxo3a/BIM通路延缓吡咯替尼耐药作用机制研究
Aspirin与自噬通路及核转录因子FoxG1在听觉系统退行性变中的协同调控机制研究
  • 批准号:
    81800915
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    贺祖宏
  • 依托单位:
Aspirin联合牙周膜干细胞再生全脱位牙牙周组织机制研究
  • 批准号:
    81760190
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32.0万元
  • 批准年份:
    2017
  • 负责人:
    王璇
  • 依托单位:
可注射温敏型水凝胶缓释Aspirin碳点和EPO促牙周组织再生的研究
  • 批准号:
    81600879
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    徐晓薇
  • 依托单位: